Candel Therapeutics, Inc.

CADL

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001841387

SEC filings (opens in a new tab)

In the last 90 days, Candel Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 137 institutions reported holding it in 13F filings for Q2 2026, worth $518.9M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Candel Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of CADL: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	114	3	137	+26
Shares	43.4M	172.4K	50.4M	+7.14M (+16.5%)
Value	$212.9M	$847.2K	$518.9M	+$306.8M (+144.7%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (39)

Institutions that held Candel Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CADL in Q2 2026
Institution	Shares	Value	% of portfolio
Marshall Wace, LLP	300,641	$3.10M	0.00%
Wellington Management Group LLP	205,745	$2.12M	0.00%
D. E. Shaw & Co., Inc.	108,933	$1.12M	0.00%
Jump Financial, LLC	106,840	$1.10M	0.01%
Trexquant Investment LP	101,317	$1.04M	0.01%
Squarepoint Ops LLC	75,211	$774.7K	0.00%
Y-Intercept (Hong Kong) Ltd	68,472	$705.3K	0.01%
Cookson Peirce & Co Inc	60,000	$618.0K	0.02%
Fisher Asset Management, LLC	57,800	$595.3K	0.00%
Rafferty Asset Management, LLC	56,260	$579.5K	0.00%
Militia Capital Management LLC	50,100	$516.0K	0.09%
Mercer Global Advisors Inc	49,154	$506.3K	0.00%
Cary Street Partners Financial LLC	43,100	$443.9K	0.01%
SEI Investments Co	42,910	$442.0K	0.00%
American Century Companies Inc	42,642	$439.2K	0.00%
Walleye Capital LLC	40,690	$419.1K	0.00%
Virtus Investment Advisers, Inc.	38,224	$393.7K	0.09%
Winton Group Ltd	37,300	$384.2K	0.01%
Jain Global LLC	29,244	$301.2K	0.00%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	29,236	$301.1K	0.00%
Virtu Financial LLC	28,997	$299.0K	0.01%
Profund Advisors LLC	28,677	$295.4K	0.01%
Letko, Brosseau & Associates Inc	25,050	$258.0K	0.00%
Schonfeld Strategic Advisors LLC	17,473	$180.0K	0.00%
DRW Securities, LLC	14,272	$147.0K	0.01%
Voya Investment Management LLC	12,602	$129.8K	0.00%
Prudential Financial Inc	11,005	$113.4K	0.00%
ProShare Advisors LLC	10,700	$110.2K	0.00%
Davenport & Co LLC	10,200	$105.1K	0.00%
Pacer Advisors, Inc.	940	$10.0K	0.00%
Clear Street Markets LLC	585	$6.03K	0.00%
Cape Investment Advisory, Inc.	555	$5.72K	0.00%
SRS Capital Advisors, Inc.	211	$2.17K	0.00%
Clearstead Advisors, LLC	206	$2.12K	0.00%
EverSource Wealth Advisors, LLC	25	$258	0.00%
Farther Finance Advisors, LLC	20	$206	0.00%
National Bank of Canada	17	$175	0.00%
Larson Financial Group LLC	13	$134	0.00%
LifeSteps Financial, Inc.	1	$10	0.00%

Sold out (13)

Institutions that held Candel Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CADL in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Vestal Point Capital, LP	1,125,000	$5.51M
Heights Capital Management, Inc	775,000	$3.80M
ExodusPoint Capital Management, LP	227,468	$1.11M
Woodline Partners LP	156,700	$767.8K
Stonepine Capital Management, LLC	102,500	$502.3K
Bridgeway Capital Management, LLC	75,100	$368.0K
HRT Financial LP	32,015	$156.0K
Krilogy Financial LLC	30,065	$155.1K
Taylor Financial Group, Inc.	16,600	$81.3K
Renaissance Technologies LLC	12,780	$62.6K
Mirabella Financial Services LLP	12,489	$61.2K
Group One Trading, L.P.	8,760	$42.9K
MAI Capital Management	39	$192

Not filed for Q2 2026 yet (3)

Institutions that held Candel Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CADL in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	171,978	$845.3K
CWM, LLC	387	$1.90K
Sunbelt Securities, Inc.	16	$78